Skip to Content

Big news:Composer has joined SoFi!Read the blog post

Symphonies
AI Native Biotechs
Today’s Change
—

A symphony is an automated trading strategy — Learn more about symphonies here

About

Equal-weight basket of AI-native biotech/life-sciences stocks (e.g., Recursion, Schrödinger, Ginkgo). 100% in this theme, no scheduled rebalancing, so positions drift. Highly concentrated and volatile; driven by clinical, partnership, and AI adoption news.
NutHow it works
Puts 100% into a single, equal-weight basket of seven “AI-first” biotech/life-sciences stocks: RXRX (Recursion), SDGR (Schrödinger), CERT (Certara), ABSI (AbSci), DNA (Ginkgo Bioworks), RLAY (Relay Therapeutics), and HYFT (please confirm company). No scheduled rebalancing; weights drift over time.
CheckmarkValue prop
Out-of-sample this AI-native biotech basket offers superior risk-adjusted returns vs the S&P 500: Sharpe ~4.0 vs ~2.2, positive alpha, and strong upside driven by AI-enabled drug discovery and bioscience tools.
1M
3M
6M
YTD
1Y
3Y
Max
www.composer.trade
Performance
Compared to selected benchmarks
AlphaBetaR2R
SPY
-0.221.770.290.54
Performance Metrics
Cumulative ReturnAnnualized ReturnTrailing 1M ReturnTrailing 3M ReturnSharpe Ratio
SPY
85.88%13.34%4.34%11.4%0.82
AI Native Biotechs
-46.73%-11.94%27.19%59.04%0.05
Initial Investment
$10,000.00
Final Value
$5,326.89
Regulatory Fees
$0.64
Total Slippage
$2.72
Invest in this strategy
OOS Start Date
Jun 22, 2026
Trading Setting
Threshold 12%
Type
Stocks
Category
Biotech, ai-driven drug discovery, life sciences software, equal-weight, concentrated, small/mid-cap, no scheduled rebalancing
Tickers in this symphonyThis symphony trades 7 assets in total
Ticker
Type
ABSI
Absci Corporation Common Stock
Stocks
CERT
Certara, Inc. Common Stock
Stocks
DNA
Ginkgo Bioworks Holdings, Inc.
Stocks
HYFT
MindWalk Holdings Corp. Common Stock
Stocks
RLAY
Relay Therapeutics, Inc. Common Stock
Stocks
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
Stocks
SDGR
Schrodinger, Inc. Common Stock
Stocks

FAQ

A Composer symphony is an automated trading strategy that executes trades based on parameters of your choice. Some symphonies are similar to holding one ETF in normal conditions and rotating to a different ETF when market conditions shift, for example a 5% drop in the S&P 500, while others use complex rules with dozens of triggers. However, complex doesn’t always mean better. A simple, well-structured symphony can be just as effective as an intricate one. Learn more about how symphonies work here.

"AI Native Biotechs" is currently performing the same as yesterday today. Performance updates in real time during market hours.

"AI Native Biotechs" is currently allocated toDNA, ABSI, CERT, HYFT, RLAY, RXRXandSDGR. Holdings automatically adjust as market conditions change based on the strategy's rules.

Year-to-date, "AI Native Biotechs" has returned 682.70%. You can adjust the performance chart above to view returns across different time horizons.

The maximum drawdown for "AI Native Biotechs" is 6.30%. The maximum drawdown measures the largest peak-to-trough decline. It's an important metric to evaluate risk and the strategy's behavior during market stress.

To invest in "AI Native Biotechs", simply click the Invest button on this page. You'll need to open an account with Composer if you don't have one yet, then you can start investing. Composer will automatically execute the trades for you based on the strategy's rules. Composer also supports trading individual stocks, ETFs, and options.